VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Viatris Inc. for alleged violations of federal securities laws related to misleading information about the company's operations and regulatory issues [1][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased Viatris securities between August 8, 2024, and February 26, 2025, inclusive [2]. - The Complaint alleges that Viatris misrepresented the impact of a warning letter issued by the FDA regarding its Indore, India facility, downplaying it as a "minor headwind" [3]. Group 2: Next Steps - Investors who suffered losses in Viatris have until June 3, 2025, to request to be appointed as lead plaintiff in the case [4]. - A copy of the Complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. - Bronstein, Gewirtz & Grossman, LLC is recognized for representing investors in securities fraud class actions and has recovered significant amounts for investors [6].